A randomized comparison of early enteral nutrition and standard care post allogeneic stem cell transplantation.

Not Applicable

Completed

• Conditions: Diet and Nutrition - Other diet and nutrition disorders; haematological malignancies

• Registration Number: ACTRN12615000284561
• Lead Sponsor: Sarah Andersen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Over 18 years old, no contraindications to nasogastric tube insertion, having an allogeneic transplant with cyclophosphamide and total body irradiation or fludarabine melphalan conditioning. Also must have ability to give informed consent.

Exclusion Criteria

Known anatomic deformity preventing NGT insertion or undergoing a nonmyeloablative conditioning regimen (Fludarabine/ Cyclophosphamide or Fludarabine/total body irradiation).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is tolerability of supplemental enteral nutrition (EN) as defined by the percentage of randomized patients who do not tolerate goal enteral feeding so must either discontinue EN or commence ‘top up’ parenteral nutrition. This is assessed by regularly speaking to the patients and the treating team plus reading the patients medical record. [Assessed at completion of the study ]